These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 16314619)

  • 21. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
    Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
    Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
    Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two radiation regimens and prognostic factors for brain metastases in nonsmall cell lung cancer patients.
    Rades D; Schild SE; Lohynska R; Veninga T; Stalpers LJ; Dunst J
    Cancer; 2007 Sep; 110(5):1077-82. PubMed ID: 17614294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain metastases from breast carcinoma: validation of the radiation therapy oncology group recursive partitioning analysis classification and proposition of a new prognostic score.
    Le Scodan R; Massard C; Mouret-Fourme E; Guinebretierre JM; Cohen-Solal C; De Lalande B; Moisson P; Breton-Callu C; Gardner M; Goupil A; Renody N; Floiras JL; Labib A
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):839-45. PubMed ID: 17544592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.
    Rades D; Lohynska R; Veninga T; Stalpers LJ; Schild SE
    Cancer; 2007 Dec; 110(11):2587-92. PubMed ID: 17893909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multimodality management of non-small cell lung cancer patients with brain metastases.
    Ricciardi S; de Marinis F
    Curr Opin Oncol; 2010 Mar; 22(2):86-93. PubMed ID: 20009927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiotherapy in lung adenocarcinoma with brain metastases: effects of activating epidermal growth factor receptor mutations on clinical response.
    Gow CH; Chien CR; Chang YL; Chiu YH; Kuo SH; Shih JY; Chang YC; Yu CJ; Yang CH; Yang PC
    Clin Cancer Res; 2008 Jan; 14(1):162-8. PubMed ID: 18172267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efaproxiral (Allos Therapeutics).
    Kolman A
    IDrugs; 2003 Aug; 6(8):795-801. PubMed ID: 12917776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intensified local treatment and systemic therapy significantly increase survival in patients with brain metastases from advanced breast cancer - a retrospective analysis.
    Bartsch R; Fromm S; Rudas M; Wenzel C; Harbauer S; Roessler K; Kitz K; Steger GG; Weitmann HD; Poetter R; Zielinski CC; Dieckmann K
    Radiother Oncol; 2006 Sep; 80(3):313-7. PubMed ID: 16959347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors for survival after stereotactic radiosurgery vary with the number of cerebral metastases.
    DiLuna ML; King JT; Knisely JP; Chiang VL
    Cancer; 2007 Jan; 109(1):135-45. PubMed ID: 17133440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of cerebral metastases for postoperative locally advanced non-small-cell lung cancer.
    Wang SY; Ye X; Ou W; Lin YB; Zhang BB; Yang H
    Lung Cancer; 2009 May; 64(2):238-43. PubMed ID: 18838190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gamma-knife radiosurgery as an optimal treatment modality for brain metastases from epithelial ovarian cancer.
    Lee YK; Park NH; Kim JW; Song YS; Kang SB; Lee HP
    Gynecol Oncol; 2008 Mar; 108(3):505-9. PubMed ID: 18191184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of recursive partitioning analysis grouping in patients with brain metastases from non-small-cell lung cancer.
    Gülbaş H; Erkal HS; Serin M
    Jpn J Clin Oncol; 2006 Apr; 36(4):193-6. PubMed ID: 16611661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increasing tumor volume is predictive of poor overall and progression-free survival: secondary analysis of the Radiation Therapy Oncology Group 93-11 phase I-II radiation dose-escalation study in patients with inoperable non-small-cell lung cancer.
    Werner-Wasik M; Swann RS; Bradley J; Graham M; Emami B; Purdy J; Sause W
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):385-90. PubMed ID: 17869017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of overall treatment time in patients irradiated for more than three brain metastases.
    Rades D; Kieckebusch S; Lohynska R; Veninga T; Stalpers LJ; Dunst J; Schild SE
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1509-13. PubMed ID: 17689033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gamma knife radiosurgery for multiple brain metastases from lung cancer.
    Park SH; Hwang SK; Kang DH; Lee SH; Park J; Hwang JH; Hamm IS; Park YM
    J Clin Neurosci; 2009 May; 16(5):626-9. PubMed ID: 19268596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase III trial of paclitaxel plus carboplatin with or without tirapazamine in advanced non-small-cell lung cancer: Southwest Oncology Group Trial S0003.
    Williamson SK; Crowley JJ; Lara PN; McCoy J; Lau DH; Tucker RW; Mills GM; Gandara DR;
    J Clin Oncol; 2005 Dec; 23(36):9097-104. PubMed ID: 16361616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of different treatment approaches for one to two brain metastases in elderly patients.
    Rades D; Pluemer A; Veninga T; Schild SE
    Strahlenther Onkol; 2008 Nov; 184(11):565-71. PubMed ID: 19016014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase 2 trial of whole-brain radiotherapy combined with intravenous chemotherapy in patients with brain metastases from breast cancer.
    Cassier PA; Ray-Coquard I; Sunyach MP; Lancry L; Guastalla JP; Ferlay C; Gomez F; Curé H; Lortholary A; Claude L; Blay JY; Bachelot T
    Cancer; 2008 Nov; 113(9):2532-8. PubMed ID: 18780315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer.
    Yuan S; Sun X; Li M; Yu J; Ren R; Yu Y; Li J; Liu X; Wang R; Li B; Kong L; Yin Y
    Am J Clin Oncol; 2007 Jun; 30(3):239-44. PubMed ID: 17551299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.